Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$6.22 +0.14 (+2.30%)
At close: Sep 30, 2026 · 4:00 PM EDT

Orchestra BioMed Holdings (OBIO) EBITDA Margin (2022 - 2026)

Updated

Orchestra BioMed Holdings (OBIO) recorded EBITDA Margin of -25295.45% in Q2 2026, down 22993.30 percentage points from -2302.15% a year earlier and down 5308.18 percentage points from the prior quarter.

Analysis

Orchestra BioMed Holdings (OBIO) EBITDA Margin (2022 - 2026) Analysis & Trends

On a TTM basis, Orchestra BioMed Holdings' EBITDA Margin came in at -180.27% as of Jun 30, 2026, up 2229.48 percentage points year-over-year; for FY2025, it came in at -153.75%, up 2272.06 percentage points from FY2024.

  • Annual EBITDA Margin has a three-year change of +764.30 percentage points (FY2022 to FY2025).
  • Across earlier years, EBITDA Margin came in at -2425.82% in FY2024 (-570.05 pp), -1855.76% in FY2023 (-937.70 pp) and -918.06% in FY2022.
  • The Q2 2026 figure is the lowest quarterly EBITDA Margin in data going back to Q1 2022.
  • On a year-over-year basis, EBITDA Margin rose in three of the last eight quarters, with an average year-over-year change of -4369.12 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 6580.61 percentage points in Q4 2025, against a drop of 22993.30 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -19987.27% (Q1 2026), 22.11% (Q4 2025) and -2349.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 21.86%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 41.08%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 25.55%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 31.93%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 24.62%
10 Orchestra BioMed Holdings 365.44 Mn -31.16 Mn 63,000.00 -25,295.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25,295.45%
Mar 31, 2026 -19,987.27%
Dec 31, 2025 22.11%
Sep 30, 2025 -2,349.83%
Jun 30, 2025 -2,302.15%
Mar 31, 2025 -2,170.28%
Dec 31, 2024 -6,558.50%
Sep 30, 2024 -1,648.02%
Jun 30, 2024 -2,157.46%
Mar 31, 2024 -2,314.35%
Dec 31, 2023 -4,736.26%
Sep 30, 2023 -3,449.40%
Jun 30, 2023 -1,407.98%
Mar 31, 2023 -985.74%
Dec 31, 2022 -884.68%
Sep 30, 2022 -860.96%
Jun 30, 2022 -1,891.27%
Mar 31, 2022 -586.61%
API Access

Orchestra BioMed Holdings EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OBIO&period=max&api_key=YOUR_API_KEY